Investor Relations

Stock price graph

GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.

For investor information, please contact IR@genmarkdx.com.

Annual Reports

2014 Proxy Statement

2013 Annual Report

2013 Proxy Statement

2012 Annual Report

2011 Annual Report

2012 Proxy Statement


Recent Releases

Apr 16, 2015
GenMark Announces Positive Preliminary Q1 Financial Results and ePlex™ Update

Feb 24, 2015
GenMark Reports Fourth Quarter and Full Year 2014 Results

View all releases »

Events

May 5, 2015 at 4:30 PM ET
GenMark Diagnostics First Quarter Earnings Conference Call

View all events »

Related Links

Stock Quote
Price:
10.86
Change:
- 2.02
Day High:
12.93
Day Low:
10.58
Volume:
1,124,700
NASDAQ
GNMK
4:00 PM ET on Apr 17, 2015
Delayed at least 20 minutes.
Provided by eSignal.